← board
CPMV
distress 4/10 · elevated risk$0.67+5%today-36% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
0%
Price & events
+4.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
+5.5%
1D
+5.5%
1W
+0.0%
1M
-3.0%
3M
+4.0%
6M
+67.7%
1Y
+12.3%
2Y
-61.7%
5Y
-80.2%
All
Overview
- Market Cap
- $4.88M
- Volume
- 400
- 52 Week Range
- $0.31 – $1.05
- Total Shares
- 7.24M
- Float Shares
- 819.88K
- % Held by Insiders
- 88.68%
- % Held by Institutions
- 0.00%
- RVOL
- 6.67x
- Beta
- -0.91
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 7,242,137 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.